Alicia Grande
Net Worth

Last updated:

What is Alicia Grande net worth?

The estimated net worth of Ms. Alicia Grande is at least $22,083,751 as of 27 Dec 2023. She owns shares worth $1,019,229 as insider, has earned $11,573,932 from insider trading and has received compensation worth at least $9,490,590 in Catalyst Pharmaceuticals, Inc..

What is the salary of Alicia Grande?

Ms. Alicia Grande salary is $558,270 per year as Chief Accounting Officer, Vice President, Treasurer & Chief Financial Officer in Catalyst Pharmaceuticals, Inc..

How old is Alicia Grande?

Ms. Alicia Grande is 54 years old, born in 1971.

What stocks does Alicia Grande currently own?

As insider, Ms. Alicia Grande owns shares in one company:

Company Title Shares Price per share Total value
Catalyst Pharmaceuticals, Inc. (CPRX) Chief Accounting Officer, Vice President, Treasurer & Chief Financial Officer 50,557 $20.16 $1,019,229

What does Catalyst Pharmaceuticals, Inc. do?

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

CPRX logo
CPRX
Catalyst Pharmaceuticals, Inc.
$20.16

Alicia Grande insider trading

Catalyst Pharmaceuticals, Inc.

Ms. Alicia Grande has made 25 insider trades between 2008-2023, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 200,000 units of CPRX stock on 6 Nov 2017. As of 27 Dec 2023 she still owns at least 50,557 units of CPRX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock, par value $0.001 per share 8,666 N/A N/A
Option
Restricted Stock Units 8,666 N/A N/A
Sale
Common Stock, par value $0.001 per share 30,000 $13.74 $412,200
Option
Options to purchase common stock 60,000 $1.13 $67,800
Sale
Common Stock, par value $0.001 per share 30,000 $13.79 $413,580
Option
Common Stock, par value $0.001 per share 60,000 $1.13 $67,800
Sale
Common Stock, par value $0.001 per share 20,000 $14.3 $286,000
Sale
Common Stock, par value $0.001 per share 20,000 $14.25 $285,000
Option
Common stock, par value $0.001 per share 40,000 $1.13 $45,200
Option
Options to purchase common stock 40,000 $1.13 $45,200
Sale
Common stock, par value $0.001 per share 20,000 $16.7 $334,000
Sale
Common stock, par value $0.001 per share 10,000 $16.67 $166,700
Option
Common stock, par value $0.001 per share 50,000 $1.13 $56,500
Option
Options to purchase common stock 50,000 $1.13 $56,500
Sale
Common stock, par value $0.001 per share 20,000 $16.72 $334,400
Option
Options to purchase common stock 58,216 $0.79 $45,991
Option
Common stock, par value $0.001 per share 58,216 $0.79 $45,991
Sale
Common stock, par value $0.001 per share 28,216 $16.6 $468,386
Sale
Common stock, par value $0.001 per share 10,000 $16.55 $165,500
Sale
Common stock, par value $0.001 per share 10,000 $16.52 $165,200
Sale
Common stock, par value $0.001 per share 10,000 $16.37 $163,700
Option
Options to purchase common stock 3,260 $0.79 $2,575
Sale
Common stock, par value $0.001 per share 41,784 $16.46 $687,765
Option
Common stock, par value $0.001 per share 38,524 $0.79 $30,434
Option
Common stock, par value $0.001 per share 3,260 $0.79 $2,575
Option
Options to purchase common stock 38,524 $0.79 $30,434
Option
Restricted Stock Units 11,166 N/A N/A
Option
Common Stock, par value $0.001 per share 11,166 N/A N/A
Option
Common Stock, par value $0.001 per share 14,667 N/A N/A
Option
Restricted Stock Units 14,667 N/A N/A
Sale
Common Stock, par value $0.001 per share 120,000 $16.53 $1,983,240
Sale
Common Stock, par value $0.001 per share 60,000 $15.77 $946,080
Sale
Common Stock, par value $0.001 per share 60,000 $11.9 $713,940
Sale
Common Stock, par value $0.001 per share 90,000 $13.5 $1,214,640
Sale
Common Stock, par value $0.001 per share 50,000 $15.57 $778,650
Sale
Common Stock, par value $0.001 per share 17,000 $14.28 $242,760
Sale
Common Stock, par value $0.001 per share 20,000 $14.2 $284,000
Sale
Common Stock, par value $0.001 per share 20,000 $14.14 $282,800
Sale
Common Stock, par value $0.001 per share 11,095 $14.4 $159,768
Option
Options to purchase common stock 31,425 $2.53 $79,505
Option
Common Stock, par value $0.001 per share 19,259 $2.53 $48,725
Option
Options to purchase common stock 99,316 $2.53 $251,269
Option
Options to purchase common stock 19,259 $2.53 $48,725
Sale
Common Stock, par value $0.001 per share 19,259 $13.7 $263,848
Option
Common stock, par value $0.001 per share 31,425 $2.53 $79,505
Sale
Common stock, par value $0.001 per share 31,425 $13.87 $435,896
Option
Common stock, par value $0.001 per share 99,316 $2.53 $251,269
Option
Common Stock, par value $0.001 per share 14,667 N/A N/A
Option
Restricted Stock Units 14,667 N/A N/A
Sale
Common stock, par value $0.001 per share 13,000 $5.68 $73,879
Option
Common stock, par value $0.001 per share 70,000 $3.12 $218,400
Option
Options to purchase common stock 70,000 $3.12 $218,400
Option
Options to purchase common stock 100,000 $3.12 $312,000
Option
Common stock, par value $0.001 per share 100,000 $3.12 $312,000
Sale
Common stock, par value $0.001 per share 100,000 $3.12 $312,000
Option
Common Stock, par value $0.001 per share 14,666 N/A N/A
Option
Restricted Stock Units 14,666 N/A N/A
Option
Options to purchase common stock 200,000 $0.47 $94,000
Option
Common stock, par value $0.001 per share 200,000 $0.47 $94,000
Option
Common stock, par value $0.001 per share 40,000 $1.09 $43,600
Option
Options to purchase common stock 40,000 $1.09 $43,600
Option
Common stock, par value $0.001 per share 90,000 $0.9 $81,000
Option
Options to purchase common stock 90,000 $0.9 $81,000
Purchase
Common Stock, par value $0.001 per share 20,000 $0.55 $10,900
Purchase
Common Stock, par value $0.001 per share 17,300 $0.57 $9,861
Purchase
Common Stock, par value $0.001 per share 4,200 $0.65 $2,730
Purchase
Common Stock, par value $0.001 per share 5,000 $0.65 $3,250
Purchase
Common Stock, par value $0.001 per share 2,500 $1.85 $4,625
Purchase
Common Stock, par value $0.001 per share 1,000 $1.85 $1,850

Catalyst Pharmaceuticals key executives

Catalyst Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: